ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 277 filers reported holding ICU MED INC in Q3 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,564,230 | -39.4% | 29,949 | -9.2% | 0.00% | -50.0% |
| Q2 2023 | $5,879,023 | -28.7% | 32,993 | -34.0% | 0.00% | -33.3% |
| Q1 2023 | $8,243,382 | +7.8% | 49,972 | +2.9% | 0.00% | 0.0% |
| Q4 2022 | $7,649,905 | +7.0% | 48,577 | +2.3% | 0.00% | 0.0% |
| Q3 2022 | $7,151,000 | -10.0% | 47,487 | -1.7% | 0.00% | 0.0% |
| Q2 2022 | $7,945,000 | -24.4% | 48,331 | +2.5% | 0.00% | 0.0% |
| Q1 2022 | $10,503,000 | -7.0% | 47,173 | -0.8% | 0.00% | 0.0% |
| Q4 2021 | $11,291,000 | +4.7% | 47,576 | +2.9% | 0.00% | -25.0% |
| Q3 2021 | $10,786,000 | +22.7% | 46,216 | +8.2% | 0.00% | +33.3% |
| Q2 2021 | $8,794,000 | -10.9% | 42,727 | -11.1% | 0.00% | -25.0% |
| Q1 2021 | $9,868,000 | -1.0% | 48,038 | +3.3% | 0.00% | 0.0% |
| Q4 2020 | $9,971,000 | +8.0% | 46,486 | -8.0% | 0.00% | 0.0% |
| Q3 2020 | $9,231,000 | +0.4% | 50,511 | +1.2% | 0.00% | 0.0% |
| Q2 2020 | $9,195,000 | +5.1% | 49,888 | +15.0% | 0.00% | -20.0% |
| Q1 2020 | $8,751,000 | +19.2% | 43,371 | +10.5% | 0.01% | +66.7% |
| Q4 2019 | $7,341,000 | +23.9% | 39,235 | +5.7% | 0.00% | 0.0% |
| Q3 2019 | $5,925,000 | -32.7% | 37,121 | +6.2% | 0.00% | -40.0% |
| Q2 2019 | $8,803,000 | +79.4% | 34,947 | +70.4% | 0.01% | +66.7% |
| Q1 2019 | $4,907,000 | +9.9% | 20,505 | +5.4% | 0.00% | 0.0% |
| Q4 2018 | $4,466,000 | -14.5% | 19,449 | +5.2% | 0.00% | -25.0% |
| Q3 2018 | $5,225,000 | +0.6% | 18,479 | +4.5% | 0.00% | 0.0% |
| Q2 2018 | $5,193,000 | +37.3% | 17,686 | +18.1% | 0.00% | +33.3% |
| Q1 2018 | $3,781,000 | -42.7% | 14,980 | -51.0% | 0.00% | -40.0% |
| Q4 2017 | $6,598,000 | +18.6% | 30,544 | +2.1% | 0.01% | +25.0% |
| Q3 2017 | $5,561,000 | +11.8% | 29,918 | +3.8% | 0.00% | 0.0% |
| Q2 2017 | $4,972,000 | +24.4% | 28,831 | +10.1% | 0.00% | +33.3% |
| Q1 2017 | $3,998,000 | +6.1% | 26,185 | +2.3% | 0.00% | -25.0% |
| Q4 2016 | $3,768,000 | +113.2% | 25,593 | +82.7% | 0.00% | +100.0% |
| Q3 2016 | $1,767,000 | +302.5% | 14,010 | +257.9% | 0.00% | – |
| Q2 2016 | $439,000 | +38.1% | 3,914 | +28.1% | 0.00% | – |
| Q1 2016 | $318,000 | -4.2% | 3,055 | +3.8% | 0.00% | – |
| Q4 2015 | $332,000 | +3.4% | 2,943 | 0.0% | 0.00% | – |
| Q3 2015 | $321,000 | +14.6% | 2,943 | 0.0% | 0.00% | – |
| Q2 2015 | $280,000 | +17.6% | 2,943 | +13.1% | 0.00% | – |
| Q1 2015 | $238,000 | +43.4% | 2,602 | +31.3% | 0.00% | – |
| Q4 2014 | $166,000 | +25.8% | 1,982 | 0.0% | 0.00% | – |
| Q3 2014 | $132,000 | – | 1,982 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |